Champions Oncology Inc
F:2I3

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
F:2I3
Watchlist
Price: 5.45 EUR -3.54% Market Closed
Market Cap: 74.1m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one 2I3 stock under the Base Case scenario is 6.3 EUR. Compared to the current market price of 5.45 EUR, Champions Oncology Inc is Undervalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

2I3 Relative Value
Base Case
6.3 EUR
Undervaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.6
P/S
P/S
Price to Sales
1.6
vs History
63
vs Industry
61
Median 3Y
1.5
Median 5Y
2
Industry
4.1
Forward
1.4
More Details
19.1
P/E
P/E
Price to Earnings
19.1
vs History
38
vs Industry
Median 3Y
-7.9
Median 5Y
-7.8
Industry
32.2
Forward
29
More Details
12.2
P/OCF
P/OCF
Price to OCF
12.2
vs History
41
vs Industry
35
Median 3Y
10
Median 5Y
11.4
Industry
20.6
More Details
13.1
P/FCFE
P/FCFE
Price to FCFE
13.1
vs History
34
vs Industry
14
Median 3Y
-9.3
Median 5Y
-11.3
Industry
34.9
More Details
23.8
P/B
P/B
Price to Book Value
23.8
vs History
19
vs Industry
100
Median 3Y
14.2
Median 5Y
17.7
Industry
2.7
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
66
vs Industry
57
Median 3Y
1.4
Median 5Y
1.8
Industry
4
Forward
1.3
More Details
2.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.8
vs History
76
vs Industry
58
Median 3Y
3.1
Median 5Y
3.6
Industry
8.7
More Details
12.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.4
vs History
49
vs Industry
3
Median 3Y
-9
Median 5Y
12.4
Industry
17.7
Forward
25.5
More Details
16.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.5
vs History
39
vs Industry
Median 3Y
-7.5
Median 5Y
-7.3
Industry
24.5
Forward
-315.5
More Details
10.8
EV/OCF
EV/OCF
Enterprise Value to OCF
10.8
vs History
41
vs Industry
38
Median 3Y
7.9
Median 5Y
9.6
Industry
19.3
More Details
11.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11.5
vs History
39
vs Industry
15
Median 3Y
-9.1
Median 5Y
-9.1
Industry
24.3
More Details
4.4
EV/IC
EV/IC
Enterprise Value to IC
4.4
vs History
49
vs Industry
11
Median 3Y
4
Median 5Y
4.4
Industry
2.5
More Details

Multiples Across Competitors

2I3 Competitors Multiples
Champions Oncology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Champions Oncology Inc
F:2I3
89.8m EUR 1.6 19.1 12.4 16.5
US
PerkinElmer Inc
LSE:0KHE
995.2B USD 355.6 3 489.5 1 227.3 2 494.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
184.6B USD 4.3 28 21.5 26.9
US
Danaher Corp
NYSE:DHR
151B USD 6.3 44.2 23.1 34.7
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.5 55.6 32.3 44.9
CH
Lonza Group AG
SIX:LONN
38.7B CHF 5.5 52.8 38.5 38.5
CN
WuXi AppTec Co Ltd
SSE:603259
280.9B CNY 6.6 20.4 21.9 21.9
US
Agilent Technologies Inc
NYSE:A
33.8B USD 5.1 29 19.7 23.2
US
IQVIA Holdings Inc
NYSE:IQV
32.5B USD 2.1 26.3 13.1 19.7
US
Mettler-Toledo International Inc
NYSE:MTD
27.3B USD 7.1 32.9 23.9 26.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
17.3B EUR 6 76.6 26.2 45.4

See Also

Summary
2I3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
2I3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2I3 stock valuation using valuation multiples.
Wall Street Estimates
2I3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2I3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 275,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.